Asian Journal of Social Pharmacy ›› 2022, Vol. 17 ›› Issue (1): 23-33.

Previous Articles     Next Articles

Suggestions on Foreign Pharmaceutical Enterprises Dealing with China’s Drug Centralized Procurement – Taking the First Batch of Implementation Results as an Example

  

  • Online:2022-03-17 Published:2022-03-18

Abstract: Objective To analyze the impact of the first batch of centralized drug procurement on foreign pharmaceutical enterprises since the national centralized drug procurement policy has brought great impact on pharmaceutical market, and put forward some suggestions on their marketing transformation in China. Methods Firstly, the documents of the drug centralized procurement were studied, and then the sales figures before and after the implementation of the policy were retrieved from MiNET. At the same time, the relevant business adjustment information of foreign pharmaceutical enterprises was collected for analysis. Results and Conclusion The sales of related products of foreign pharmaceutical enterprises have dropped sharply, so they have stripped off these products and reduced their staff. It is suggested that foreign pharmaceutical enterprises should adjust the structure of sales team, strengthen the layout of the market in the county, and accelerate the introduction of innovative drugs to cope with centralized drug procurement.

Key words: centralized procurement, foreign pharmaceutical enterprise, drug price, marketing, reform

Trendmd